mRNA licensing agreements surge 800% amid GSK lawsuits
An 800% increase in licensing deal values indicates growing confidence in mRNA technology.
Covid-19
NIH selects Emergex’s T cell vaccine for trials under Project NextGen
Moderna blamed after children offered £1,500 to take part in Covid-19 trial
Testosterone could influence men’s immune response to Covid-19
As mpox spreads, ‘national governments have a moral responsibility to help’
What is mpox and how big of a threat is it?
Entos and Aegis announce dosing of first subject in Covid-19 vaccine trial
AB Science touts positive Phase II Covid-19 data for masitinib
